Literature DB >> 7322455

Central sites and mechanisms of action of nicotine.

J A Rosecrans, L T Meltzer.   

Abstract

Research conducted in this laboratory over the last ten years has been directed towards determining possible CNS sites and mechanisms by which nicotine is producing its psychopharmacological effects. To accomplish these goals, a drug discrimination paradigm was utilized in which rats were trained to detect nicotine using a two-lever operant procedure. In this situation nicotine acted as a discriminative stimulus (DS) to correct lever responding. In other words rats had to be able to differentiate nicotine's effects from saline in order to obtain a food reinforcement. The ability of nicotine to exert its DS effects appear to be dependent upon a stimulation of central nicotinic-cholinergic receptors which are stereospecific to (-)-nicotine. Interestingly, the nicotine DS could not be mimicked or potentiated by elevating brain acetylcholine levels centrally suggesting that the receptor action was non-cholinergic. Additional studies indicated that nicotine is acting at both reticular formation and hippocampus sites. The hippocampal site of nicotine action also appears to be dependent on a dopamine neuron connection as well.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7322455     DOI: 10.1016/0149-7634(81)90020-8

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  13 in total

Review 1.  Nicotine dependence: a preventable risk factor for other diseases.

Authors:  C Cohen; J E Henningfield
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

Review 2.  Health consequences of using smokeless tobacco: summary of the Advisory Committee's report to the Surgeon General.

Authors:  J W Cullen; W Blot; J Henningfield; G Boyd; R Mecklenburg; M M Massey
Journal:  Public Health Rep       Date:  1986 Jul-Aug       Impact factor: 2.792

3.  Nicotine as a typical drug of abuse in experimental animals and humans.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2005-10-05       Impact factor: 4.530

Review 4.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983.

Authors:  I P Stolerman; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Isolation of a nicotine binding site from rat brain by affinity chromatography.

Authors:  L G Abood; W Latham; S Grassi
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

Review 6.  Effects of nicotine in experimental animals and humans: an update on addictive properties.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Handb Exp Pharmacol       Date:  2009

7.  Mecamylamine reverses physostigmine-induced attenuation of scopolamine-induced hyperactivity.

Authors:  M F O'Neill; A G Fernández; R W Gristwood; J M Palacios
Journal:  J Neural Transm Gen Sect       Date:  1994

8.  Discriminative stimulus properties of cocaine in pigeons.

Authors:  R de la Garza; C E Johanson
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Pharmacological classification of the abuse-related discriminative stimulus effects of trichloroethylene vapor.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  J Drug Alcohol Res       Date:  2014-03-01

Review 10.  More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.

Authors:  M J Moerke; L R McMahon; J L Wilkerson
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.